Navigation Links
Interventions to promote repeat breast cancer screening with mammography
Date:6/29/2010

Researchers have been trying to determine the best strategy for women who can potentially benefit from repeat mammography screening. A recent meta-analysis shows that there is no one single intervention that is best, according to a study published online June 29 in The Journal of the National Cancer Institute.

Regular mammography screening has been shown to reduce breast cancer mortality in women between the ages of 50 and 74 by approximately 23%. However, until 2001, only about half of eligible women have made use of repeat mammography screening. But the surge in recent usage of mammography (women getting them within the past two years), has far outpaced regular or repeat mammography usage. Various interventions, including educational outreach and counseling, have been tried to encourage more regular use of mammography.

To investigate the effectiveness of these intervention strategies, Sally W. Vernon, MD, of the Center for Health Promotion and Prevention Research at the University of Texas-Houston, and colleagues, looked at 25 studies that reported estimates of repeat screening for interventions and control groups. They looked at electronic databases through August 2009.

The intervention strategies used by the studies were grouped into three categories: reminders, education/motivation, and counseling. The studies were also classified according to the counseling protocols used, and whether single or multiple interventions were used.

The authors found that the studies were heterogeneous, that is, they differed in their conclusions about similar interventions. This finding could be attributed to a lack of standardization among interventions, or different populations or settings.

They noted that this meta-analysis was limited in its ability to measure the effects of interventions for repeat screening because several studies used interventions not explicitly designed to promote repeat mammography; in addition, many of the studies were conducted over ten years ago.

The authors concluded that integration of individual behavioral interventions with structural-level changes may create sustainable improvements in adherence to breast cancer screening. But more studies are needed.

"If we are to reap the benefits of mortality reduction from mammography screening, we need a better understanding of the determinants of repeat screening behavior so that we can develop more effective interventions," the authors write.

In an accompanying editorial, Dr. Jeanne Mandelblatt of Georgetown University Medical Center and Diana Buist, PhD, of the Group Health Research Institute at the University of Washington, write that one of the obstacles to defining the most effective interventions for promoting regular mammography adherence is that women may be choosing not to use mammography because of publicity about mis-diagnoses.

"It could be reasonably argued that we should better spend our efforts in discovering better early detection tests rather than continuing to invest in getting a few more women to regularly use a flawed technology," the authors write, adding that proteomics and gene expression profiling methods are two of the tools used to identify potential biomarkers for screening tests.

"It is no longer enough to simply conduct more interventions to understand which work best in motivating individuals to undergo repeat cancer screening," the authors write. "New paradigms, guided by evidence from modeling, novel trials, and new scientific discovery, will be needed to realize the promise of eliminating the burden of cancer."


'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. United Nations Foundation Commends G8 Leaders for Accelerating Support for Proven Interventions to Improve Women's and Children's Health
2. JACC: Cardiovascular Interventions now abstracted and indexed by Thomson Reuters
3. Childhood obesity interventions must begin early, UCSF experts say
4. Childhood Obesity Interventions Must Begin Early, UCSF Experts Say
5. Synergy between behavioral and pharmacologic interventions for ADHD
6. Experts call for acceleration of research and interventions for prematurity and stillbirth
7. New Anti-Aging Skin Care Line Promotes Penetration
8. TV Food Ads Promote Bad Diets
9. ‘Protein Lady' Announces New Blog to Promote Importance of Protein-Rich Diet
10. DRW Weight Loss Debuts Website to Promote Healthy Living and Nutritional Aids
11. Brain Health Expert Says OASIS Promotes Brain Fitness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: